Anna Rita Migliaccio
Departments of Hematology
Oncology and Molecular Medicine
Istituto Superiore Sanità
Italy
Name/email consistency: high
- Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease. Migliaccio, A.R., Martelli, F., Verrucci, M., Migliaccio, G., Vannucchi, A.M., Ni, H., Xu, M., Jiang, Y., Nakamoto, B., Papayannopoulou, T., Hoffman, R. Exp. Hematol. (2008)
- Role of thrombopoietin in mast cell differentiation. Migliaccio, A.R., Rana, R.A., Vannucchi, A.M., Manzoli, F.A. Ann. N. Y. Acad. Sci. (2007)
- The return of Romeo. Scientists' international mobility and the future of research in Europe. Migliaccio, A.R., Philipsen, S. EMBO Rep. (2006)
- A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis. Vannucchi, A.M., Bianchi, L., Paoletti, F., Pancrazzi, A., Torre, E., Nishikawa, M., Zingariello, M., Di Baldassarre, A., Rana, R.A., Lorenzini, R., Alfani, E., Migliaccio, G., Migliaccio, A.R. Blood (2005)
- Role of GATA-1 in normal and neoplastic hemopoiesis. Migliaccio, A.R., Rana, R.A., Vannucchi, A.M., Manzoli, F.A. Ann. N. Y. Acad. Sci. (2005)
- GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. Migliaccio, A.R., Rana, R.A., Sanchez, M., Lorenzini, R., Centurione, L., Bianchi, L., Vannucchi, A.M., Migliaccio, G., Orkin, S.H. J. Exp. Med. (2003)
- Cell therapy: filling the gap between basic science and clinical trials October 15-17, 2001, Rome, Italy. Migliaccio, A.R., Quarto, R., Piacibello, W. Stem. Cells (2003)
- Robust levels of long-term multilineage reconstitution in the absence of stem cell self-replication in W/Wv mice transplanted with purified stem cells. Migliaccio, A.R., Lorenzini, R., Vannucchi, A.M., Spangrude, G.J., Migliaccio, G. J. Hematother. Stem Cell Res. (2003)
- In vivo expansion of purified hematopoietic stem cells transplanted in nonablated W/Wv mice. Migliaccio, A.R., Carta, C., Migliaccio, G. Exp. Hematol. (1999)









